Peter W. Roelvink
- Genetics top 1%
- Molecular Biology top 5%
- Oncology top 5%
- Infectious Diseases top 5%
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- Thomas J. WickhamImre KovesdiDouglas E. BroughDavid A. EinfeldAlena LizonováYuan LiRobert W. FinbergJeffrey M. Bergelson
- Topics
- Virus-based gene therapy research (16 papers)CAR-T cell therapy research (9 papers)Viral gastroenteritis research and epidemiology (7 papers)
- Cited by
- GeneticsOncologyInfectious Diseases
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Peter W. Roelvink
20 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Genetics 1.8k
- Molecular Biology 1.3k
- Oncology 834
- Infectious Diseases 467
- Cardiology and Cardiovascular Medicine 284
Countries citing papers authored by Peter W. Roelvink
This map shows the geographic impact of Peter W. Roelvink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Roelvink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Roelvink more than expected).
Fields of papers citing papers by Peter W. Roelvink
This network shows the impact of papers produced by Peter W. Roelvink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Roelvink. The network helps show where Peter W. Roelvink may publish in the future.
Co-authorship network of co-authors of Peter W. Roelvink
This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Roelvink. A scholar is included among the top collaborators of Peter W. Roelvink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Roelvink. Peter W. Roelvink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 56 | |
| 2 | 89 | |
| 3 | 23 | |
| 4 | 46 | |
| 5 | 9 | |
| 6 | Advances towards targetable adenovirus vectors for gene therapy. | 18 |
| 7 | 59 | |
| 8 | 17 | |
| 9 | 44 | |
| 10 | 176 | |
| 11 | 151 | |
| 12 | 1 | |
| 13 | 332 | |
| 14 | 67 | |
| 15 | 93 | |
| 16 | The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and Fbreakdown → | 524 |
| 17 | 276 | |
| 18 | 8 | |
| 19 | 6 | |
| 20 | 6 |
About Peter W. Roelvink
Peter W. Roelvink is a scholar working on Genetics, Infectious Diseases and Oncology, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (16 papers), CAR-T cell therapy research (9 papers) and Viral gastroenteritis research and epidemiology (7 papers). The work is most often cited by research in Genetics (1.8k citations), Oncology (834 citations) and Infectious Diseases (467 citations). Peter W. Roelvink has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Thomas J. Wickham, Imre Kovesdi, Douglas E. Brough, David A. Einfeld, Alena Lizonová, Yuan Li, Robert W. Finberg, Jeffrey M. Bergelson, Ian Kirby and George Santis. Their work appears in journals such as Science, Journal of Clinical Investigation and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.